ArticleFrontiers in oncology2026

Efficacy and safety of combining TACE with atezolizumab/bevacizumab versus TACE alone: a retrospective propensity score-matched cohort study in HBV-related hepatocellular carcinoma.

Jie Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.